# Profectus Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/profectus-biosciences

- Industry: Pharmaceuticals
- Headquarters: Baltimore, US
- Website: profectusbiosciences.com
- Total disclosed funding: $12M
- Latest round: Series C (Apr 17, 2014)
- Investors on record: 1

## About

Profectus Biosciences, is based in Baltimore, US and is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases with a goal of reducing morbidity and mortality.

## Funding rounds

- Series C, Apr 17, 2014, $7.3M — Cross Atlantic Capital Partners
- Series C, Jul 22, 2009, $5M — Cross Atlantic Capital Partners

## Investors

- Cross Atlantic Capital Partners (https://capitalatlas.ai/funds/cross-atlantic-capital-partners) — Series C